Lixte Biotechnology
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -1,009 | -4 | -6 |
EBIT | -1,009 | -971 | -1,032 |
Net Income | -1,010 | -971 | -1,032 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -819 | -789 | -902 |
Cash | 2,595 | 3,414 | 4,203 |
Basic Shares | 2,249 | 2,249 | 2,249 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | 3 | -1 | -7 | 1 |
EBIT | -5,087 | -6,312 | -6,728 | -3,264 |
Net Income | -5,087 | -6,304 | -6,735 | -3,263 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,293 | -4,611 | -4,142 | -2,131 |
Cash | 4,203 | 5,353 | 4,823 | 5,069 |
Basic Shares | 1,915 | 158 | 1,347 | 1,127 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.44 |
2024-03-31 | -$0.43 |
2023-12-31 | -$0.45 |
2023-09-30 | -$0.49 |
